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In the preceding report of this series (1)  it was shown that  the  membrane 
immunofluorescence  (MIF)  reaction  observed  with  cultured  Burkitt's  lym- 
phoma (BL) cells (2, 3) depends apparently upon the presence of Epstein-Barr 
virus  (EBV)  (4)  and  to  a  considerable  extent  also  upon  the  extent  of  the 
persistent  EBV  infection.  Recent  observations indicate  that  EBV  is  closely 
related to, if not identical with, the causative agent of infectious mononucleosis 
(IM). Antibodies to the virus were found to arise de novo in the course of the 
disease  (5,  6)  and  continuous  lines  of  blastoid  cells  derived  from  peripheral 
leukocytes  of  IM  patients  were  shown  to  harbor  regularly  EBV  (7)  and  to 
reveal in appreciable percentages of the cells the C group chromosomal marker 
(8) which was previously reported to be present in cultured BL cells (9,  10).  It 
has not been possible to differentiate antigenically between the virus found in 
cultures of BL or IM cells by the methods employed thus far (11).  It was of 
interest  therefore to determine whether blastoid cells of BL  and IM cultures 
would share membrane antigens detectable by the MIF test and, if found to be 
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true,  whether  IM  patients  would  respond  with  formation  of  corresponding 
antibodies.  Both questions were answered in the affirmative,  as will be docu- 
mented in this report. 
Materials and Methods 
Cd/s.--The establishment and maintenance of blastoid cell lines from peripheral leukocytes 
of IM patients  (7) and from Burkitt tumor biopsies (12) have been fully described. 
Sera.--Pertinent data on the BL patient serum Mutua employed as standard reagent have 
been recorded (1). Sets of serial sera from IM patients  were selected from those previously 
used for titrations of antibodies to EBV (5, 6), and included a specimen taken prior to exposure 
and several others collected at various times after onset of illness. Additional sera were ob- 
tained  from individuals with weN-documented attacks of IM as long as 20 yr ago. Control 
sera were derived from patients with varicella virus infections who possessed no antibodies to 
EBV. 
Iramunofluorescence Tests.--The techniques employed for detection of membrane fluores- 
cence (MIF), and EBV antigen-containing cells, as well as for titration  of antibodies to EBV, 
have been fully described (i-3, 5, 13). The results of the MIF tests are expressed in terms of 
fluorescence indices (FI) which were calculated by the established formula (1). 
RESULTS 
Membrane  Fluorescence with  Blastoid  Cells Derived from 
Leukocytes  of  IM  Patients 
A  total of eight blastoid cell cultures initiated with leukocytes of patients  in 
the acute stage of IM were sent from Philadelphia to Stockholm. When shipped, 
the cultures were estimated  to contain from 0.5 to 4% ceils which synthesized 
EBV  antigen.  These  cultures  were  tested  on arrival  for membrane  immuno- 
fluorescence  with  the  aid  of  the  standard  serum  of  Burkitt  tumor  patient 
Mutua and then maintained further for subsequent assays. Table I  records the 
initial  results.  The first six lines listed were strongly positive in the MIF test 
and the remaining two negative. 
As has  been pointed  out  (7),  estimates  of EBV-positive  cells  in  relatively 
young cultures of IM ceils are often hampered by (a) considerable aggregation 
of the  cells  resulting  in correspondingly dense  and multilayered  areas  in cell 
smears; (b) relatively high percentages of dying or dead ceils which may reveal 
a  granular,  yellowish autofluorescence; and  (c)  presence of globulin-producing 
cells which may react in, and confuse, the results of indirect assays for viral anti- 
gen.  Because  of these difficulties,  the percentages of EBV-positive ceils can be 
considered  only approximations.  It was noted  furthermore  (7)  that  the  per- 
sistent EBV infections in IM cell cultures are more unstable generally than in 
established  BL  ceil  lines.  Once  the  IM  cells  commence to  grow rapidly  and 
are maintained under conditions for optimal cellular replication, the percentages 
of EBV-positive cells decline steeply. A similarly rapid decrease in MIF activity 
was seen  with  the first  three  IM cultures  shipped  to Stockholm. The results 
obtained with the E.H.  IV line serve as an example (Fig. 1). Within 5-6 wk of r,.LEL,',r Er  AL  1023 
further  cultivation in Stockholm, the FI values declined from  >0.5  to  <0.2. 
The line maintained in Philadelphia under similar conditions showed a decrease 
in EBV-positive cells from 2-3 to <0.2 %. The last five cultures listed in Table I 
TABLE I 
Membrane Fluorescence Obtained with Standard Burkitt Tumor Patient Serum Mutua and Cell 
Lines Deri~ed  from Leukocytes of Patients in the Acute Stage of Infectious Mononucleosis 
Cell line  Age of line at time of test  EBV test(% -b ceils)  MIF test (FI) 
E.H. IV 
SCH 
MIL 
KAP 
COW 
MAZ 
WHI 
NON 
d~ys 
53 
38 
38 
88 
64 
84 
81 
88 
2-3 
1-2 
1-2 
2-4 
1-2 
3-4 
0.5-1 
0.5-1 
0.56 
0.61 
0.61 
0.43 
0.48 
0.59 
0.03 
0.09 
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FIG. 1.  Decline of membrane fluorescence reactivity, expressed as fluorescence index (FI) 
with Mutua's serum, in the E.H.IV line as a function of time of cultivation after the line had 
been received in Stockholm. 
were sent later, and these were maintained on a  reduced feeding schedule, i.e., 
fed once every 7-10 days instead of at 4-7 day intervals. In these cultures, the 
MIF and EBV activities were retained although with some day by day fluctua- 
tions. For these reasons it became essential for determination of antibodies to 
membrane  antigens to pretest all cells to be used for MIF  reactions with the 
standard Mutua serum. 1024  EB  VIRAL  AND  CELL  MEMBRANE  I:M:MUNOFLUORESCEN'CE.  II 
Development of Antibodies to Membrane Antigens of Cultured Burkitt Tumor Cells 
in Sera of IM _Patients 
Sets  of  sera  from  patients  with  infectious  mononucleosis,  which  included 
specimens collected several weeks to years before onset  (5,  6),  were examined 
by the indirect immunofluorescence techniques  (a)  for antibodies  to EB  virus 
using acetone-fixed smears of cells from the EB 3  line of Burkitt  tumor origin 
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Fie.  2. Anti-EBV and membrane fluorescence  reactivity in four sets of sera obtained from 
donors before and after infectious mononucleosis (IM). Membrane fluorescence  reactivity was 
tested  against  live cells of membrane reactive  Burkitt  cell lines (see text).  The membrane 
reactivity of the standard Burkitt reference serum (Mutua) is shown for comparison. 
(4)  maintained  on  arginine-deficient  medium  for  3-5  days  (5);  and  (b)  for 
antibodies  to  cell  membrane  antigens  of  live  cells  of  several  Burkitt  tumor 
lines,  i.e.,  Jijoye,  Annah,  Esther,  Silfere,  or Wilkister  (1,  12).  The  choice  of 
cells for this test on given days was dictated by the results of preliminary MIF 
tests with  the standard  Mutua  serum  (1).  Only cells with fluorescence indices 
(FI) of 0.4 or greater were used for the purpose. 
Fig. 2 summarizes the results obtained with four sets of sera. The FI values 
represent  the averages of several tests with from 3-4 different cell lines.  Nega- 
tive or insignificant  MIF reactions were seen only with sera collected prior to 
infection or in the early acute phase of the disease. With progressing time after KLEIN  ET  AL.  1025 
onset,  the  FI values increased gradually to highly significant levels  and  ap- 
proached or matched those obtained with the standard Mutua serum. Peak FI 
values were attained long after maximal anti-EBV and (not shown) heterophile 
antibody titers had been reached.  Exhaustive adsorption of some of the sera 
with sheep erythrocytes failed to reduce the MIF reactions. 
TABLE II 
Differences  in  Membrane Immunofluorescence  Obtained  with  Various  Burldtt  Cell  Lines  and 
Serial Sera  "tom Four I~, "eaious Mononucleosis  Patients 
Cell lines used for MIF reaction (FI) 
Patient 
BAX 
CAS 
CHI 
RID 
Time after 
onset 
days 
Pre 
15 
8O 
Pre 
10 
50 
Pre 
7 
42 
Pre 
10 
44 
Pre 
8 
12 
32 
Anti-EBV 
tlter 
<10 
20--40 
40 
<10 
40 
20-40 
<10 
80-150 
40 
<10 
150 
150 
<10 
40 
40 
20 
Ann~a 
0.66 
0.81 
0.93 
0.68 
0.80 
0.55 
0.17 
0.75 
0.75 
0.00 
0.56 
0.65 
0.50 
0.89 
0.45 
0.50 
Esther  Silfere  Average 
0.10  0.20  0.32 
0.84  0.36  0.67 
0.67  0.41  0.67 
0.44 
0.94 
0.79 
0.41 
0.66 
0.77 
0.43 
GOD 
0.10 
1.50 
0.52 
0.34 
0.24 
0.61 
0.21 
0.40 
0.42 
0.39 
0.90 
0.54 
0.32 
0.48 
0.72 
0.10 
0.48 
0.54 
0.20 
0.77 
0.61 
0.46 
The above four sets of sera, as well as four additional ones, gave principally 
similar results regardless of the cell lines  employed for the MIF test. With four 
other sets of sera,  the results were not as uniform (Table II). In these cases, 
MIF reactions were observed with the pre-IM sera and several of the cell lines 
employed so that the average FI values ranged from 0.10 to nearly 0.4. Never- 
theless,  subsequent  sera,  collected  from  7  to  80  days after  onset  of  illness, 
revealed substantial increases in the fluorescence indices.  For every set of sera 
there was at least one cell line, however, which failed to react significantly with 
the pre-IM specimen but yielded very strong MIF reactions with  the  acute 
stage and later sera. 
Additional tests were carried out with sera from (a) patients in the early and 1026  EB  VIRAL  AND  CELL  MEMBRANE  rMMUNOFLUORESCENCE.  II 
late acute stages of IM; (b) individuals who had well-documented histories of 
IM as long as 37  yr ago; and  (c)  children  recently recovered from varicella 
which  gave  titers  of  <1:10 in  the  EBV  reaction.  The  fluorescence  indices 
obtained  with  the  first  group of  sera  from  seven  patients  conformed to  the 
patterns  shown in  Fig.  2.  The  sera  of  the  second  group revealed  anti-EBV 
titers ranging from 1: 20 to 1:160 (Table III) and highly significant FI values 
which were comparable to those obtained with the standard Mutua serum. The 
seven sera in  the last  group gave insignificant MIF reactions except for one 
TABLE III 
Membrane Immunofluorescence Reactions with Sera from Individuals with Long Past Histories 
of Infectious Mononucleosis 
Serum donor 
K.W. 
T.D. 
M. A. C. 
H.L. 
W.H. 
F.O. 
R. W. M. 
F.F. 
Mutua (control) 
Time after IM 
yr 
1 
3 
4 
8 
5 
>10 
18 
20 
37 
Anti-EBV 
titer 
40 
80 
160 
80 
80 
80 
80 
80 
20 
640 
No. of tests 
MIF 
No. of cell 
lines  Average FI 
0.45 
0.62 
0.58 
0.53 
0.60 
0.49 
0.53 
0.53 
0.67 
0.52 
which yielded an  FI value of 0.45,  but well  below that of the Mutua serum 
control which was 0.82 in this set of tests. 
Comparison of MIF Reactions Elicited by IM Patients' Sera in Cultured Burkitt 
Tumor and Infectious Mononucleosis Cells 
The sets of sera from patients K. W.  and E. H. were tested repeatedly for 
MIF activity using both cultured Burkitt tumor cells and ceils of lines  derived 
from IM patients. It is seen (Table IV)  that comparable results were obtained 
with both types of ceils from three lines  each. The FI values rose from insig- 
niticant levels in  the pre-IM and early acute stage sera  to highly significant 
figures in later sera.  The peak values attained were of similar orders as those 
recorded with the Mutua control serum in both sets of ceils. A fourth IM ceil 
line  (WHI) was included in one of the tests.  These ceils  failed to yield MIF 
reactions with the Mutua serum and the results with the sera of K. W.  were 
likewise negative. Of special significance  is the fact that patient E. H. developed 
antibodies  which  reacted  not  only with  cell  membrane  antigens  of  Burkitt KLEIN  ET  AL.  1027 1028  EB VIP,  AL AND  CELL MEMBP,  ANE  T~M'UNOFLUORESCENCE. II 
tumor cells but apparently equally well with blastoid ceils derived from cul- 
tures of her own leukocytes initiated 2 months after onset of her illness (5). 
DISCUSSION 
The above data indicate (a) that cultured blastoid cells derived from periph- 
eral leukocytes of patients in the acute stage of infectious mononucleosis (IM) 
possess membrane antigens which are similar to, if not identical with, those 
found in Burkitt lymphoma (BL) cells from biopsies or continuous cultures; 
and (b)  that patients with infectious mononucleosis develop antibodies to the 
membrane antigens of both types of ceils  including autochthonous cell lines 
(E.H.). These findings extend earlier reports which showed (a) that established 
cell lines of either kind as a rule harbor EB virus particles in a fraction of the 
cells  which  thus  far  appear  to  be  indistinguishable  antigenically (11)  and 
therefore certainly belong into the same subgroup of herpes viruses, if they do 
not represent a single type; and (b) that, in the course of IM, patients regularly 
form de novo antibodies to EBV as present in BL or IM cultures (11). 
Evidence has been presented in the preceding paper of this series  (1)  that 
EBV is linked, at least indirectly, to the elaboration of membrane antigens of 
BL cells and, as shown in the present report, a similar relation appears to hold 
also for cultured blastoid cells derived from leukocytes of IM patients. The 
membrane imrounofluorescence (MIF) reaction of cultured Burkitt tumor cells 
was shown to depend apparently on the presence of EBV and, to a considerable 
degree also upon the extent of the EBV infection in the cultures.  Similarly, 
cultured blastoid ceils derived from IM patients revealed MIF activity if about 
1% or more were EBV-positive. When the extents of the EBV infection declined 
on further maintenance of the cultures, the MIF test gradually turned negative. 
There is little doubt that the antigen-antibody reactions involved in the two 
immunofluorescence tests are distinct as evident from several observation: (a) 
Generally, MIF-positive cells in both BL and IM cultures exceed EBV-positive 
ceils by a  factor of 10 or greater; (b)  cells from BL biopsies or early cultures 
may yield strong MIF with Burkitt tumor patients' sera even though few, if 
any, EBV-contalnlng cells may be detectable, whereas in well-established BL 
cultures the reverse may occasionally be found, i.e., relatively high percentages 
of EBV-positive cells in the absence of significant MIF activity (1). Preliminary 
tests have shown that sera from IN[ patients may yield MIF reactions also with 
ceils  from Burkitt  tumor biopsies;  and  (c)  early acute stage  sera from IM 
patients may reveal already high, if not maximal, titers of antibodies to EBV, 
whereas significant and peak FI values are attained, as a nile, only in later sera. 
Thus, no constant relationship between the results of the two immunofluores- 
cence tests became evident. 
In the majority of IM patients studied, the choice of the target cells for the 
MIF reaction  appeared  to  be  immaterial.  In  a  few patients,  however,  the 
pre-IM sera reacted to a  considerable extent with the surface of some of the KL~.m  ET  ~.  1029 
Burkitt  tumor cell  lines but not with others.  This discrepancy is presently 
unexplained. It is, of course, possible that at times isoantigens may play a role 
in the test, (3). It is also conceivable that prolonged storage of sera in the frozen 
state may render them unsuitable for this test at least with cells from some of 
the lines employed. The four pre-IM sera which yielded such discrepant results 
were collected 6-9 yr previously, whereas five of the eight presera which did not 
present this problem had been stored for < 6 years. 
As in the case  of  the  EBV  test  (6),  the MIF reactions are unrelated to 
heterophile antibodies because (a) sera of Burkitt tumor patients which react 
strongly in the MIF as well as EBV tests do not contain heterophile antibodies; 
(b) heterophile antibodies in IM arise as a rule earlier than those to membrane 
antigens; (c) antibodies active in the MIF and EBV tests seem to persist for 
years, if not for life, whereas heterophile antibodies disappear within months 
after onset of IM;  and  (~)  exhaustive adsorption of IM patients'  sera with 
sheep  erythrocytes removes the heterophile antibodies without affecting the 
MIF and EBV reactions. 
Neither the EBV found in BL or IM cultures nor the MIF reactions exhibited 
by both types of cells could thus far be distinguished antigenically. The question 
remains whether the virus, which apparently is causally related to IM, may 
also induce, directly or indirectly, Burldtt's lymphoma. The assumption that 
EBV represents merely a  passenger in Burkitt tumors and cultures derived 
therefrom would be difficult to reconcile with the fact that all African Burkitt 
tumor patients studied to date had high levels of antibodies to EBV antigens 
(5, 13), whereas only about 50 % of the sera collected from comparable African 
control children reacted with EBV antigens (5, 14) and positive MIF tests are 
also less frequently observed with such sera (2, 3). 
SUMMARY 
Blastoid cell cultures derived from leukocytes of patients in the acute stage 
of infectious mononucleosis (IM) and harboring Epstein-Barr (EB) virus in at 
least 1% of the cells were found to possess antigens in their membranes which 
presently  are  indistinguishable from  those  detected in  Burkitt's lymphoma 
(BL) cells by the techniques employed. It was noted that, in the course of IM, 
antibodies are formed which react in indirect immunofluorescence tests with 
membrane antigens of live cells from Burkitt tumor lines as well as from IM 
leukocyte cultures, including an autochthonous line in the case of one patient. 
Sets of sera from IM patients were tested which included a  serum collected 
weeks to years before onset of illness.  In the majority of these the pre-IM 
serum failed to react in membrane immunofluorescence (MIF) tests with any 
of several Burkitt tumor cell lines employed, but in some cases the presera 
reacted with cells of some but not others of the lines. Possible explanations for 
these discrepant results have been discussed. 
The antibodies involved in the MIF test are evidently distinct from those 1030  EB  VIRAL  AND  CELL  MEMBRANE  IMAfUNOFLUORESCENCE.  II 
responsible  for the  EBV and heterophile  reactions.  Maximal  MIF activity is 
attained long after the other two antibodies  have reached maximal titers  and 
antibodies  to EBV and membrane antigens  seem to persist  for years whereas 
the heterophile reaction turns negative within a few months. 
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